Shares of Aurobindo Pharma Ltd. declined as much as 4% in Wednesday's trading session after details from the Form 483 issued to its Unit-7 facility were accessed. The US FDA had inspected Aurobindo's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results